114 related articles for article (PubMed ID: 722112)
1. Differential susceptibility of Propionibacterium acnes, P. granulosum and P. avidum to free fatty acids.
Ko HL; Heczko PB; Pulverer G
J Invest Dermatol; 1978 Dec; 71(6):363-5. PubMed ID: 722112
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of Staphylococcus aureus and group A, B, C, and G streptococci to free fatty acids.
Heczko PB; Lütticken R; Hryniewicz W; Neugebauer M; Pulverer G
J Clin Microbiol; 1979 Mar; 9(3):333-5. PubMed ID: 457851
[TBL] [Abstract][Full Text] [Related]
3. Anti-bacterial and anti-inflammatory properties of capric acid against Propionibacterium acnes: a comparative study with lauric acid.
Huang WC; Tsai TH; Chuang LT; Li YY; Zouboulis CC; Tsai PJ
J Dermatol Sci; 2014 Mar; 73(3):232-40. PubMed ID: 24284257
[TBL] [Abstract][Full Text] [Related]
4. Effect of lipase activities of Propionibacterium granulosum and Propionibacterium acnes.
Higaki S; Nakamura M; Kitagawa T; Morohashi M; Yamagishi T
Drugs Exp Clin Res; 2001; 27(5-6):161-4. PubMed ID: 11951573
[TBL] [Abstract][Full Text] [Related]
5. Propionicins, bacteriocins produced by Propionibacterium avidum.
Ko HL; Pulverer G; Jeljaszewicz J
Zentralbl Bakteriol Orig A; 1978 Sep; 241(3):325-8. PubMed ID: 726736
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobiol susceptibility of Propinibacterium acnes and related microbial species.
Hoeffler U; Ko HL; Pulverer G
Antimicrob Agents Chemother; 1976 Sep; 10(3):387-94. PubMed ID: 984781
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial Activity of Pomegranate and Green Tea Extract on Propionibacterium Acnes, Propionibacterium Granulosum, Staphylococcus Aureus and Staphylococcus Epidermidis.
Li Z; Summanen PH; Downes J; Corbett K; Komoriya T; Henning SM; Kim J; Finegold SM
J Drugs Dermatol; 2015 Jun; 14(6):574-8. PubMed ID: 26091382
[TBL] [Abstract][Full Text] [Related]
8. Effects of pH on biomass, maximum specific growth rate and extracellular enzyme production by three species of cutaneous propionibacteria grown in continuous culture.
Greenman J; Holland KT; Cunliffe WJ
J Gen Microbiol; 1983 May; 129(5):1301-7. PubMed ID: 6311940
[TBL] [Abstract][Full Text] [Related]
9. In vivo treatment of Propionibacterium acnes infection with liposomal lauric acids.
Pornpattananangkul D; Fu V; Thamphiwatana S; Zhang L; Chen M; Vecchio J; Gao W; Huang CM; Zhang L
Adv Healthc Mater; 2013 Oct; 2(10):1322-8. PubMed ID: 23495239
[TBL] [Abstract][Full Text] [Related]
10. Action of three species of Propionibacteria (P. granulosum, P. acnes, P. avidum) on experimental tumor systems in mice.
Roszkowski W; Kobus M; Luczak M; Ko HL; Szmigielski S; Laskowska B; Pulverer G; Jeljaszewicz J
Zentralbl Bakteriol A; 1980 Mar; 246(3):405-14. PubMed ID: 6252722
[TBL] [Abstract][Full Text] [Related]
11. Identification of Propionibacterium acnes and related organisms by precipitin tests with trichloroacetic acid extracts.
Cummins CS
J Clin Microbiol; 1976 Aug; 2(2):104-10. PubMed ID: 972178
[TBL] [Abstract][Full Text] [Related]
12. [Effect of free fatty acids on Propionibacterium acnes and Staphylococcus epidermidis].
Nakagawa M; Nishijima S; Asada Y
Nihon Hifuka Gakkai Zasshi; 1986 Sep; 96(10):1007-11. PubMed ID: 3795558
[No Abstract] [Full Text] [Related]
13. Production of hyaluronidase by propionibacteria from different origins.
Höffler U
Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):123-9. PubMed ID: 44604
[TBL] [Abstract][Full Text] [Related]
14. [Differentiation of various Propionibacterium species from acne-vulgaris efflorescences].
Lentze I; Ko HL; Höffler U
Hautarzt; 1979 May; 30(5):242-7. PubMed ID: 156167
[TBL] [Abstract][Full Text] [Related]
15. Minocycline effectively reduces acid producted by Propionibacterium granulosum.
Higaki S; Kitagawa T; Morohashi M; Yamagishi T
J Dermatol; 2002 Jan; 29(1):20-2. PubMed ID: 11837569
[TBL] [Abstract][Full Text] [Related]
16. Resistance of propionibacteria to antibiotics used in the treatment of acne.
Brown JM; Poston SM
J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016
[TBL] [Abstract][Full Text] [Related]
17. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure.
Eady EA; Cove JH; Holland KT; Cunliffe WJ
Br J Dermatol; 1989 Jul; 121(1):51-7. PubMed ID: 2527056
[TBL] [Abstract][Full Text] [Related]
18. Solid Lipid Nanoparticles Loaded with Retinoic Acid and Lauric Acid as an Alternative for Topical Treatment of Acne Vulgaris.
Silva EL; Carneiro G; De Araújo LA; Trindade Mde J; Yoshida MI; Oréfice RL; Farias Lde M; De Carvalho MA; Dos Santos SG; Goulart GA; Alves RJ; Ferreira LA
J Nanosci Nanotechnol; 2015 Jan; 15(1):792-9. PubMed ID: 26328443
[TBL] [Abstract][Full Text] [Related]
19. Electrophoretic protein patterns and enzyme mobilities in anaerobic coryneforms.
Gross CS; Ferguson DA; Cummins CS
Appl Environ Microbiol; 1978 Jun; 35(6):1102-8. PubMed ID: 677876
[TBL] [Abstract][Full Text] [Related]
20. Comparative genomics reveals distinct host-interacting traits of three major human-associated propionibacteria.
Mak TN; Schmid M; Brzuszkiewicz E; Zeng G; Meyer R; Sfanos KS; Brinkmann V; Meyer TF; Brüggemann H
BMC Genomics; 2013 Sep; 14():640. PubMed ID: 24053623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
